| Literature DB >> 36092987 |
Helen Zhang1, Ifeanyirochukwu Onochie1, Lara Hilal1, N Ari Wijetunga1, Elizabeth Hipp1, David M Guttmann1, Oren Cahlon1, Charles Washington1, Daniel R Gomez1, Erin F Gillespie1,2.
Abstract
Purpose: A radiation anatomist was trained and integrated into clinical practice at a multi-site academic center. The primary objective of this quality improvement study was to determine whether a radiation anatomist improves the quality of organ-at-risk (OAR) contours, and secondarily to determine the impact on efficiency in the treatment planning process. Methods and Materials: From March to August 2020, all patients undergoing computed tomography-based radiation planning at 2 clinics at Memorial Sloan Kettering Cancer Center were assigned using an "every other" process to either (1) OAR contouring by a radiation anatomist (intervention) or (2) contouring by the treating physician (standard of care). Blinded dosimetrists reported OAR contour quality using a 3-point scoring system based on a common clinical trial protocol deviation scale (1, acceptable; 2, minor deviation; and 3, major deviation). Physicians reported time spent contouring for all cases. Analyses included the Fisher exact test and multivariable ordinal logistic regression.Entities:
Year: 2022 PMID: 36092987 PMCID: PMC9449753 DOI: 10.1016/j.adro.2022.101009
Source DB: PubMed Journal: Adv Radiat Oncol ISSN: 2452-1094
Figure 1Study schema and randomization process for standard-of-care and intervention study arms.
Study cohort characteristics
| Variable | Anatomist, No. (%) (n = 196) | MD, No. (%) (n = 183) | |
|---|---|---|---|
| Treatment location | >.99 | ||
| Clinical site 1 | 75 (38) | 70 (38) | |
| Clinical site 2 | 121 (62) | 113 (62) | |
| Disease site | .31 | ||
| Brain | 23 (12) | 17 (9.3) | |
| Breast | 23 (12) | 23 (13) | |
| GI | 40 (20) | 23 (13) | |
| H&N | 21 (11) | 32 (17) | |
| Lung | 23 (12) | 26 (14) | |
| Metastases | 33 (17) | 34 (19) | |
| Other | 19 (9.7) | 14 (7.7) | |
| Spine | 14 (7.1) | 14 (7.7) | |
| RT technique | .53 | ||
| 3D CRT | 30 (15) | 36 (20) | |
| IMRT/VMAT | 107 (55) | 96 (52) | |
| SRS/SBRT | 59 (30) | 51 (28) |
Abbreviations:3D CRT = 3-dimensional conformal radiation therapy; GI = gastrointestinal; H&N = head and neck; IMRT = intensity modulated radiation therapy; Mets =;RT = radiation therapy; SBRT = stereotactic body radiation therapy; SRS = stereotactic radiosurgery; VMAT = volumetric modulated arc therapy.
χ2 test of independence.
Genitourinary, gynecological, sarcoma, lymphoma, and skin.
Figure 2Organ-at-risk quality score frequency in the standard of care and radiation anatomist intervention groups.
Subset analysis of OAR quality ratings between SOC and anatomist groups, by disease site
| Disease site and study arm | OAR rating, No. (%) | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | Mean | ||
| All OARs (n = 249) | |||||
| MD | 75 (65) | 30 (26) | 10 (9) | 1.44 | < .001 |
| Anatomist | 117 (87) | 15 (11) | 2 (2) | 1.14 | |
| Head and neck (n = 40) | |||||
| MD | 12 (50) | 9 (38) | 3 (13) | 1.63 | .17 |
| Anatomist | 13 (81) | 3 (19) | 0 (0) | 1.19 | |
| Lung (n = 35) | |||||
| MD | 17 (100) | 0 | 0 | 1.00 | .10 |
| Anatomist | 14 (78) | 4 (22) | 0 | 1.22 | |
| GI (n = 49) | |||||
| MD | 10 (56) | 7 (39) | 1 (6) | 1.50 | < .001 |
| Anatomist | 30 (97) | 1 (3) | 0 | 1.03 | |
| Mets (n = 44) | |||||
| MD | 16 (76) | 3 (14) | 2 (10) | 1.33 | .39 |
| Anatomist | 21 (91) | 1 (4) | 1 (4) | 1.13 | |
| Spine (n = 23) | |||||
| MD | 5 (45) | 4 (36) | 2 (18) | 1.73 | .03 |
| Anatomist | 11 (92) | 0 | 1 (8) | 1.17 | |
Abbreviations: OAR = organ at risk; SOC = standard of care.
Indicates statistical significance (P < .005) by Fisher exact test.
Factors associated with OAR contour quality on multivariable ordinal logistic regression
| Variable | Odds ratio | 95% CI | |
|---|---|---|---|
| Contoured by | |||
| Treatment technique | |||
| Disease site |
Abbreviations: 3D RT = 3-dimensional radiation therapy; CI = confidence interval; GI = gastrointestinal; H&N = head and neck; OAR = organ at risk.
Treatment technique is a dichotomized variable of 3D conformal or volumetric modulated arc therapy / intensity modulated radiation therapy and stereotactic radiosurgery/ stereotactic body radiation therapy.
Disease site is a dichotomized variable; “other” includes brain, breast, genitourinary, gynecological, lung, metastatic, sarcoma, lymphoma, and skin.
Figure 3Time spent contouring by physician in the standard-of-care (without anatomist) and intervention (with anatomist) groups.